Bioworld Financial Watch articles from January 2007

Bioworld Financial Watch archives from January 2007

2006: industry holds steady, consolidates, gathers steam.(Big Buyouts A Major Theme)
January 1, 2007... No major scandals. No breathtaking breakthroughs. In 2006, there just wasn't much beyond the ordinary that distinguished the industry, which ground along at a steady pace dotted by a few thrilling success stories, as well as the inevitable...

Biotech mergers and acquisitions: Sept. 29-Dec. 28, 2006.(Table)
January 1, 2007... I. COMPLETED MERGERS AND ACQUISITIONS Acquired By Or Company Acquired* Merged With* Date Date (Country; Symbol) (Country; Symbol) Announced Completed A. Carlsson NeuroSearch A/S...

BioWorld stock report for public biotechnology Companies.(Statistical table)
January 1, 2007... Close Close %Change Vol Company Symbol 12/22 12/29 WK YTD (000) Aastrom Biosci ASTM 1.23 1.23 0.00 -41.71 4084 Acadia Pharma ACAD 8.92...

Pancreatic cancer research on 'Threshold' of progress?('A Reason To Try Harder')(Threshold Pharmaceuticals shares boom with the rolling out of cancer drug)
January 8, 2007... Promising top-line data from a combination trial that tested glufosfamide with gemcitabine against the particularly devilish indication of pancreatic cancer lifted Threshold Pharmaceuticals Inc.'s shares in late December, but wise investors are...

Public financing of biotechnology: December 2006.
January 8, 2007... I. COMMENCED TRADING IN DECEMBER Shares Company Date Date Shares/ Out (Symbol) (#) Filed Comm. Units (M) Price (M) (@) ...

Other financings of public biotechnology companies: December 2006.
January 8, 2007... TOTAL: $1,211.07M Number Of Shares, Units Amount Company Type Of Or Warrants Raised (Symbol) (#) Financing (M) (M) ...

Venture capital and other investments in private biotechnology companies: December 2006.
January 8, 2007... FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $124.23M Company Location Date Amt. (M) Aldagen Inc. Durham, N.C. 12/19/06 $17.3 Cardioxyl Towson, Md. 12/6/06 ...

Milestone payments from corporate partners: December 2006.
January 8, 2007... TOTAL: $M54.0 Year to Date: $589.33M Company Partner Amt. Triggering (Symbol) (#*) (Country) (M) Event Cardiome Astellas Pharma $10 Milestone Pharma Corp. US Inc. ...

Money raised by biotech in 2006: January-December.(Brief article)
January 8, 2007... These graphs compare the performance of the biotech stocks for all of 2006 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 262 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public biotechnology companies.
January 8, 2007... Close Close %Change Vol Company Symbol 12/29 1/5 WK YTD (000) Aastrom Biosci ASTM 1.23 1.45 17.89 -31.28 11285 Acadia Pharma ACAD 8.79...

Go-private strategy offers fix for firms 'out of favor'.(JP Morgan Healthcare Conference)(Industry overview)
January 15, 2007... SAN FRANCISCO--"I can't remember a year that was as active and had as much transformational activity in healthcare as 2006," said Douglas Braunstein, head of investment banking in the Americas for JP Morgan, as he opened the firm's 25th...

U.S. public offerings by underwriter: Jan. 1-Dec. 31, 2006.(Chart)
January 15, 2007... Biotechnology Offering 12/31/06 Company Date Price Per Share Underwriter (Symbol) Priced Share Price AG Edwards BioMimetic...

BioWorld stock report for public biotechnology companies.(Chart)
January 15, 2007... Close Close %Change Vol Company Symbol 1/5 1/12 WK YTD (000) Aastrom Biosci ASTM 1.45 1.37 -5.52 -35.07 24152 Acadia Pharma ACAD 8.3 ...

'9' popular, but Idera putting faith in other TLRs as well.
January 22, 2007... Among people who ponder symbols, the number nine means an ending or completion, since literally it's the last of the single-digits. But research into toll-like receptors hardly finishes with investigations of popular TL9. The Phase III...

U.S. public offering performance by underwriter: Jan. 1-Dec. 31, 2006.
January 22, 2007... UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS, JAN. 1-DEC. 31, 2006: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS* Underwriter (Number Of Offerings As Lead/ Gross Number Of Offerings As Lead Or Co-manager) Proceeds (M)...

BioWorld stock report for public Biotechnology Companies.
January 22, 2007... Close Close % Change Vol Company Symbol 1/12 1/19 WK YTD (000) Aastrom Biosci ASTM 1.37 1.39 1.46 -34.12 6291 Acadia Pharma ACAD 7.44...

Amgen/Roche battle revving in profits-laden EPO space.(Analysts Vary On Likely Winner)(erythropoietin)(F. Hoffmann-La Roche Ltd.)
January 29, 2007... Amgen Inc.'s ultimate victory in the legal war more than a decade ago against Genetics Institute Inc. (GI) over erythropoietin patents went all the way to the U.S. Supreme Court, but experts last week were split on how far the latest EPO...

Clinical trials update: December 2006.(Table)
January 29, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE ChemoCentryx Inc.* Traficet-EN Orally active, anti-inflammatory agent that targets CCR9 Genmab A/S HuMax-CD20...

Non-U.S. clinical trials and regulatory actions: December 2006.(Table)
January 29, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE 4SC AG (Germany; SC12267 New type of small-molecular active FSE:VSC) agent from the class of disease- ...

FDA submissions, approvals and other actions: December 2006.(Table)
January 29, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Elan Corp. plc Tysabri Natalizumab; humanized monoclonal (Ireland; NYSE:ELN) (FDA-approved) antibody that inhibits adhesion and Biogen Idec ...

BioWorld stock report for public biotechnology companies.(Statistical table)
January 29, 2007... Close Close %Change Vol Company Symbol 1/19 1/26 WK YTD (000) Aastrom Biosci ASTM 1.39 1.37 -1.44 -35.07 3297 Acadia Pharma ACAD 7.25...